Literature DB >> 11174733

Hemodynamic unloading leads to regression of pulmonary vascular disease in rats.

S B O'Blenes1, S Fischer, B McIntyre, S Keshavjee, M Rabinovitch.   

Abstract

OBJECTIVE: Treatment options for patients with advanced pulmonary vascular disease caused by a congenital heart defect are still mainly limited to heart-lung transplantation or lung transplantation with repair of the cardiac lesion. Because we have previously shown that the structural changes associated with pulmonary hypertension can be reversed by stress unloading in an organ culture model, we now investigate whether hemodynamic unloading will lead to regression of pulmonary vascular disease in the intact animal.
METHODS: Right middle and lower lobectomy and monocrotaline injection were performed in Lewis rats (n = 22) to cause pulmonary vascular disease from a combined hemodynamic and toxic injury. Twenty-eight days later the left lungs were examined (n = 10) or exposed to normal pulmonary artery pressure for an additional 14 (n = 5) or 28 (n = 7) days by transplantation into healthy recipients. Pulmonary artery pressure, ventricular weight, and pulmonary artery morphology were evaluated in each group.
RESULTS: Pulmonary hypertension (50 vs 16 mm Hg; P <.001) and right ventricular hypertrophy (right ventricular/left ventricular weight 0.69 vs 0.32; P <.001) associated with pulmonary artery medial hypertrophy (28.2% vs 7.2% wall thickness; P <.001) and muscularization of small pulmonary arteries (92.3% vs 19.4%; P <.001) developed by day 28 (compared with untreated controls). However, transplantation into healthy recipients effectively unloaded the lungs (mean pulmonary artery pressure 17 and 24 mm Hg at 14 and 28 days after transplantation) and resulted in progressive normalization of medial hypertrophy (15.6% and 12.1% at 14 and 28 days) and muscularization (65.1% and 42.2% at 14 and 28 days) relative to nontransplanted controls (P <.005 in each case).
CONCLUSIONS: Hemodynamic unloading of lungs with pulmonary vascular disease results in progressive normalization of pulmonary artery structure. These results are the first to provide a rationale for attempting to induce regression of pulmonary vascular disease by pressure unloading of the pulmonary circulation. Methods to mechanically unload the pulmonary circulation should be critically evaluated as a strategy for staged surgical repair of congenital heart defects despite presumed irreversible pulmonary hypertension.

Entities:  

Mesh:

Year:  2001        PMID: 11174733     DOI: 10.1067/mtc.2001.111657

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

Review 1.  Molecular pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

2.  EXPRESS: Parameters associated with outcome in pediatric patients with congenital heart disease and pulmonary hypertension subjected to combined vasodilator and surgical treatments.

Authors:  Ana Maria Thomaz; Luiz Junya Kajita; Vera D Aiello; Leína Zorzanelli; Filomena Rbg Galas; Cleide G Machado; Miguel Barbero-Marcial; Marcelo B Jatene; Marlene Rabinovitch; Antonio Augusto Lopes
Journal:  Pulm Circ       Date:  2019-02-26       Impact factor: 3.017

3.  Cellular senescence impairs the reversibility of pulmonary arterial hypertension.

Authors:  Diederik E van der Feen; Guido P L Bossers; Quint A J Hagdorn; Jan-Renier Moonen; Kondababu Kurakula; Robert Szulcek; James Chappell; Francesco Vallania; Michele Donato; Klaas Kok; Jaskaren S Kohli; Arjen H Petersen; Tom van Leusden; Marco Demaria; Marie-José T H Goumans; Rudolf A De Boer; Purvesh Khatri; Marlene Rabinovitch; Rolf M F Berger; Beatrijs Bartelds
Journal:  Sci Transl Med       Date:  2020-07-29       Impact factor: 17.956

Review 4.  Congenital heart disease and pulmonary arterial hypertension in South America (2013 Grover Conference series).

Authors:  Antonio Augusto Lopes; Patricia C Flores; Gabriel F Diaz; Sonia M F Mesquita
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

5.  Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension.

Authors:  Diederik E van der Feen; Michel Weij; Annemieke Smit-van Oosten; Lysanne M Jorna; Quint A J Hagdorn; Beatrijs Bartelds; Rolf M F Berger
Journal:  J Vis Exp       Date:  2017-02-11       Impact factor: 1.355

Review 6.  A pro-con debate: current controversies in PAH pathogenesis at the American Thoracic Society International Conference in 2017.

Authors:  Wolfgang M Kuebler; Mark R Nicolls; Andrea Olschewski; Kohtaro Abe; Marlene Rabinovitch; Duncan Stewart; Stephen Y Chan; Nicholas W Morrell; Stephen L Archer; Edda Spiekerkoetter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-06-07       Impact factor: 5.464

Review 7.  Induction of vascular atrophy as a novel approach to treating restenosis. A review.

Authors:  Seung-Kee Min; Richard D Kenagy; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2007-10-22       Impact factor: 4.268

8.  Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures? Consensus statement from the Congenital Heart Disease and Pediatric Task Forces, Pulmonary Vascular Research Institute (PVRI).

Authors:  Antonio Augusto Lopes; Robyn J Barst; Sheila Glennis Haworth; Marlene Rabinovitch; Maha Al Dabbagh; Maria Jesus Del Cerro; Dunbar Ivy; Tarek Kashour; Krishna Kumar; S Harikrishnan; Michele D'Alto; Ana Maria Thomaz; Leína Zorzanelli; Vera D Aiello; Ana Olga Mocumbi; Maria Virginia T Santana; Ahmed Nasser Galal; Hanaa Banjar; Omar Tamimi; Alexandra Heath; Patricia C Flores; Gabriel Diaz; Julio Sandoval; Shyam Kothari; Shahin Moledina; Rilvani C Gonçalves; Alessandra C Barreto; Maria Angélica Binotto; Margarida Maia; Fahad Al Habshan; Ian Adatia
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

9.  The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats.

Authors:  Yinghua Guo; Longxiang Su; Yinghui Li; Na Guo; Lixin Xie; Dong Zhang; Xiaojun Zhang; Hongxia Li; Guizhi Zhang; Yajuan Wang; Changting Liu
Journal:  Heart Vessels       Date:  2013-08-10       Impact factor: 2.037

10.  Understanding Longitudinal Changes in Pulmonary Vascular Resistance After Left Ventricular Assist Device Implantation.

Authors:  Gaurav Gulati; Robin Ruthazer; David Denofrio; Amanda R Vest; David Kent; Michael S Kiernan
Journal:  J Card Fail       Date:  2021-01-12       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.